APA (7th ed.) Citation

Donskov, F., & Grüllich, C. (2020). Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma. European journal of cancer, 126, . https://doi.org/10.1016/j.ejca.2019.10.032

Chicago Style (17th ed.) Citation

Donskov, Frede, and Carsten Grüllich. "Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma." European Journal of Cancer 126 (2020). https://doi.org/10.1016/j.ejca.2019.10.032.

MLA (9th ed.) Citation

Donskov, Frede, and Carsten Grüllich. "Outcomes Based on Age in the Phase III METEOR Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma." European Journal of Cancer, vol. 126, 2020, https://doi.org/10.1016/j.ejca.2019.10.032.